INS and type 1 diabetes mellitus: Building on the knowledge of specific probiotic strains linked to host immune regulation, a randomized, double-blind, placebo-controlled trial demonstrated that probiotic supplementation alongside standard insulin therapy in T1D patients led to reductions in hemoglobin A1c (HbA1c) levels and more stable glycemic control compared to insulin therapy alone.